OBJECTIVE: Among rheumatoid arthritis (RA) patients, the intensity of pain may be out of proportion to the severity of peripheral inflammation. This observation suggests that mechanisms of central nervous system pain amplification, such as diminished conditioned pain modulation (CPM), may play a role in enhancing pain perception among some RA patients. This study was undertaken to examine the level of CPM, pressure-pain threshold, and pressure-pain tolerance among RA patients compared to healthy controls. METHODS: Fifty-eight female RA patients and 54 age-matched female control subjects without chronic pain underwent quantitative sensory testing (QST) to assess CPM levels, pressure-pain thresholds, and pressure-pain tolerance levels. CPM was induced using a cold water bath, and the pain threshold (when patients first felt pain) and pain tolerance (when pain was too much to bear) were assessed with an algometer. Associations between RA and each QST outcome were analyzed using linear regression. Sleep problems, mental health, and inflammation were assessed as mediators of the relationship between RA and QST outcomes. RESULTS: The median CPM level was 0.5 kg/cm2 (interquartile range [IQR] -0.1, 1.6) among RA patients, compared to a median of 1.5 kg/cm2 (IQR -0.1, 2.5) among controls (P=0.04). RA patients, compared to controls, had a lower pain threshold and lower pain tolerance at the wrists (each P≤0.05). In addition, RA patients had greater problems with sleep, pain catastrophizing, depression, and anxiety (P<0.0001 versus controls). Results of mediation analyses suggested that low CPM levels might be attributed, in part, to sleep disturbance (P=0.04). CONCLUSION: RA patients have impaired CPM when compared to pain-free control subjects. Sleep problems may mediate the association between RA and attenuated CPM.
OBJECTIVE: Among rheumatoid arthritis (RA) patients, the intensity of pain may be out of proportion to the severity of peripheral inflammation. This observation suggests that mechanisms of central nervous system pain amplification, such as diminished conditioned pain modulation (CPM), may play a role in enhancing pain perception among some RApatients. This study was undertaken to examine the level of CPM, pressure-pain threshold, and pressure-pain tolerance among RApatients compared to healthy controls. METHODS: Fifty-eight female RApatients and 54 age-matched female control subjects without chronic pain underwent quantitative sensory testing (QST) to assess CPM levels, pressure-pain thresholds, and pressure-pain tolerance levels. CPM was induced using a cold water bath, and the pain threshold (when patients first felt pain) and pain tolerance (when pain was too much to bear) were assessed with an algometer. Associations between RA and each QST outcome were analyzed using linear regression. Sleep problems, mental health, and inflammation were assessed as mediators of the relationship between RA and QST outcomes. RESULTS: The median CPM level was 0.5 kg/cm2 (interquartile range [IQR] -0.1, 1.6) among RApatients, compared to a median of 1.5 kg/cm2 (IQR -0.1, 2.5) among controls (P=0.04). RApatients, compared to controls, had a lower pain threshold and lower pain tolerance at the wrists (each P≤0.05). In addition, RApatients had greater problems with sleep, pain catastrophizing, depression, and anxiety (P<0.0001 versus controls). Results of mediation analyses suggested that low CPM levels might be attributed, in part, to sleep disturbance (P=0.04). CONCLUSION:RApatients have impaired CPM when compared to pain-free control subjects. Sleep problems may mediate the association between RA and attenuated CPM.
Authors: Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite Journal: Nat Rev Rheumatol Date: 2011-02-01 Impact factor: 20.543
Authors: Michael E Geisser; Kenneth L Casey; Christine B Brucksch; Christine M Ribbens; Brent B Appleton; Leslie J Crofford Journal: Pain Date: 2003-04 Impact factor: 6.961
Authors: Perry M Nicassio; Sarah R Ormseth; Morgan Kay; Mara Custodio; Michael R Irwin; Richard Olmstead; Michael H Weisman Journal: Pain Date: 2011-11-01 Impact factor: 6.961
Authors: Yvonne C Lee; Elena Massarotti; Robert R Edwards; Bing Lu; ChihChin Liu; Yuanyu Lo; Alyssa Wohlfahrt; Nancy D Kim; Daniel J Clauw; Daniel H Solomon Journal: J Rheumatol Date: 2015-12-01 Impact factor: 4.666
Authors: Megan E Petrov; Burel R Goodin; Yenisel Cruz-Almeida; Chris King; Toni L Glover; Hailey W Bulls; Matthew Herbert; Kimberly T Sibille; Emily J Bartley; Barri J Fessler; Adriana Sotolongo; Roland Staud; David Redden; Roger B Fillingim; Laurence A Bradley Journal: J Pain Date: 2015-02-25 Impact factor: 5.820
Authors: Gianluca Bagnato; Francesca Cordova; Davide Sciortino; Giovanni Miceli; Antonio Bruno; Antonino Ferrera; Donatella Sangari; Giovanni Coppolino; Maria R A Muscatello; Gianluca Pandolfo; Rocco A Zoccali; William N Roberts Journal: Rheumatol Int Date: 2017-10-30 Impact factor: 2.631
Authors: Andrew C Heisler; Jing Song; Dorothy D Dunlop; Alyssa Wohlfahrt; Clifton O Bingham; Marcy B Bolster; Daniel J Clauw; Wendy Marder; Kristine Phillips; Tuhina Neogi; Yvonne C Lee Journal: Arthritis Care Res (Hoboken) Date: 2020-07-21 Impact factor: 4.794
Authors: Michael T Smith; Patrick H Finan; Luis F Buenaver; Mercedes Robinson; Uzma Haque; Angela Quain; Erin McInrue; Dingfen Han; Jeannie Leoutsakis; Jennifer A Haythornthwaite Journal: Arthritis Rheumatol Date: 2015-05 Impact factor: 10.995
Authors: Yvonne C Lee; Clifton O Bingham; Robert R Edwards; Wendy Marder; Kristine Phillips; Marcy B Bolster; Daniel J Clauw; Larry W Moreland; Bing Lu; Alyssa Wohlfahrt; Zhi Zhang; Tuhina Neogi Journal: Arthritis Care Res (Hoboken) Date: 2018-02 Impact factor: 4.794